Security key
45408X308
- Type / Class
- Equity / COM NEW
- Total 13F shares
- 4,332,529
- Share change
- -503,748
- Total reported value
- $1,139,362
- Price per share
- $0.26
- Number of holders
- 33
- Value change
- -$137,734
- Number of buys
- 12
- Number of sells
- 9
Report period
Q1 2026
Institutions
33
Top holders
10
IGC full security history
Previous quarter: Q4 2025
IGC Pharma, Inc. SEC filings
IGC Pharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45408X308
Recent filing periods:
Top shareholders of IGC - IGC Pharma, Inc. - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
13,823,529
|
$4,700,000 | — | 22 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
1,149,268
|
$322,945 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
—
class O/S missing
|
919,641
|
$258,787 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
860,477
|
$242,169 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
—
class O/S missing
|
703,798
|
$198,049 | — | 31 Dec 2025 | |
| Rohit Goel |
3/4/5
|
Senior Director of Finance&PAO |
—
class O/S missing
|
235,000
|
$79,900 | — | 13 May 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
277,594
|
$78,115 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
—
class O/S missing
|
200,799
|
$56,505 | — | 31 Dec 2025 | |
| John E. Lynch |
3/4/5
|
Director |
—
mixed-class rows
|
396,901
mixed-class rows
|
$45,696 | — | 31 May 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
—
class O/S missing
|
154,959
|
$43,605 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
—
class O/S missing
|
113,407
|
$31,913 | — | 31 Dec 2025 | |
| DEARBORN PARTNERS LLC |
13F
|
Company |
—
class O/S missing
|
84,401
|
$23,750 | — | 31 Dec 2025 | |
| LAWOOD & CO |
13F
|
Company |
—
class O/S missing
|
75,000
|
$21,105 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
—
class O/S missing
|
65,541
|
$18,443 | — | 31 Dec 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
—
class O/S missing
|
43,400
|
$12,212 | — | 31 Dec 2025 | |
| TRUIST FINANCIAL CORP |
13F
|
Company |
—
class O/S missing
|
36,667
|
$10,318 | — | 31 Dec 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
—
class O/S missing
|
33,348
|
$9,380 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
—
class O/S missing
|
28,324
|
$7,970 | — | 31 Dec 2025 | |
| T3 Companies, LLC |
13F
|
Company |
—
class O/S missing
|
20,000
|
$5,628 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
19,869
|
$5,583 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
—
class O/S missing
|
17,707
|
$4,983 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
14,392
|
$4,050 | — | 31 Dec 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
—
class O/S missing
|
7,187
|
$2,022 | — | 31 Dec 2025 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
—
class O/S missing
|
3,000
|
$840 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
1,808
|
$508 | — | 31 Dec 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
—
class O/S missing
|
655
|
$184 | — | 31 Dec 2025 | |
| Caitlin John, LLC |
13F
|
Company |
—
class O/S missing
|
200
|
$56 | — | 31 Dec 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
—
class O/S missing
|
110
|
$31 | — | 31 Dec 2025 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
100
|
$28 | — | 31 Dec 2025 | |
| Hurley Capital, LLC |
13F
|
Company |
—
class O/S missing
|
100
|
$28 | — | 31 Dec 2025 | |
| Root Financial Partners, LLC |
13F
|
Company |
—
class O/S missing
|
100
|
$28 | — | 31 Dec 2025 | |
| DHJJ Financial Advisors, Ltd. |
13F
|
Company |
—
class O/S missing
|
80
|
$23 | — | 31 Dec 2025 | |
| Triumph Capital Management |
13F
|
Company |
—
class O/S missing
|
2
|
$1 | — | 31 Dec 2025 | |
| Terry L. Lierman |
3/4/5
|
Director |
—
class O/S missing
|
500,000
|
— | — | 17 Oct 2025 |
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2026
As of 31 Mar 2026,
IGC Pharma, Inc. - COM NEW (IGC) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,332,529 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc., RENAISSANCE TECHNOLOGIES LLC, VANGUARD FIDUCIARY TRUST CO, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, NORTHERN TRUST CORP, LAWOOD & CO, and GOLDMAN SACHS GROUP INC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
29
Q1 2026 holders
33
Holder diff
4
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.